Aurobindo Pharma Gets Warning Letter From USFDA, For API Facility

Aurobindo Pharma on Friday said it has received a warning letter from the US health regulator for its Hyderabad-based Unit I, an API (active pharmaceutical ingredient) manufacturing facility. The action follows the recent inspection of the facility by the

from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/3zVIi7w